Projects per year
Search results
-
Finished
-
-
-
A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advancedmalignancies
3/1/17 → 2/28/21
Project: Research project
-
Multicenter Expanded Access Protocol of Allogeneic Epste
Bachanova, V. & Lazaryan, A.
5/20/16 → 1/1/22
Project: Research project
-
Novartis CCTL019A2205B; MT2015-16R: Long Term Follow-Up
NOVARTIS PHARMACEUTICALS CORPORATION
4/1/16 → 9/30/23
Project: Research project
-
-
-
-
Novartis CCTL019C2201; HM2015-13: A phase II, single arm
NOVARTIS PHARMACEUTICALS CORPORATION
4/10/15 → 12/14/22
Project: Research project
-
MT2015-12 : Phase 3 Randomized, Double-Blind, Placebo Co
Bachanova, V. & Lazaryan, A.
3/31/15 → 12/31/23
Project: Research project
-
HM2014-26 DT2219 immunotoxin for the treatment of relaps
12/19/14 → 12/30/20
Project: Research project
-
-
A Multicenter study of apheresis collection of periphera
NOVARTIS PHARMACEUTICALS CORPORATION
7/1/14 → 12/31/20
Project: Research project
-
-
Phase 2, Multicenter, Single-Arm Study to Evaluate the E
JANSSEN RESEARCH & DEVELOPMENT, LLC
6/18/12 → 9/30/17
Project: Research project
-
Host regulatory T cell depletion to enhance allogeneic N
AMERICAN SOCIETY OF HEMATOLOGY
7/1/11 → 12/31/14
Project: Research project
-
-
-
The Impact of Tyrosine Kinase Inhibitors (TKI) on Philad
NOVARTIS PHARMACEUTICALS CORPORATION
1/1/11 → 12/31/13
Project: Research project
-
-
-
-
-
-
Strategies to Increase Sensitivity of CLL Tumor Cells to
CANCER AND LEUKEMIA GROUP B FOUNDATION
8/1/08 → 7/31/09
Project: Research project
-
A phase II study of oral Panobinostat in adult patients
NOVARTIS PHARMACEUTICALS CORPORATION
6/15/08 → 1/30/11
Project: Research project
-
Natural Killer Cells Expansion and Maturation by Targeti
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
7/1/07 → 1/1/09
Project: Research project
-